FDA Recall Terminated

Medtronic HMS PLUS, Hemostasis Management System. Medtronic, Inc., Cardiovascular Division, Moundsview, MN 55112. A microprocessor based, multichannel clot timing instrument with automated syringe handling for pipetting blood into single use cartridges. It performs in vitro heparin sensitivity evaluations, heparin assays, activated clotting times and platelet function evaluations.

Recall: Z-1537-2010 · Initiated March 8, 2010

Recall

Recall Number
Z-1537-2010
Event Number
55169
Firm
Medtronic Inc. Cardiac Rhythm Disease Managment
FEI Number
2182208
Product Code
JPA
Status
Terminated
Root Cause
Process change control
Initiated
March 8, 2010
Posted
May 4, 2010
Terminated
December 31, 2011
Address
8200 Coral Sea St. N.E., Saint Paul, MN, 55112

Description

Medtronic HMS PLUS, Hemostasis Management System. Medtronic, Inc., Cardiovascular Division, Moundsview, MN 55112. A microprocessor based, multichannel clot timing instrument with automated syringe handling for pipetting blood into single use cartridges. It performs in vitro heparin sensitivity evaluations, heparin assays, activated clotting times and platelet function evaluations.

Reason

The heparin assay controls may run longer than normal and in some cases, fail to give an acceptable result.

Action

Medtronic issued an "Urgent Medical Device Notification" letter dated March 8, 2010 addressed to "Dear Valued Customer" and was sent to three locations at each customer site: Risk Management, Cardiovascular Surgery and Clinical Laboratory-Point of Care. The letter described the product and the issue, provided instructions for control and patient testing. The customer was requested to return an enclosed certificate as proof of notification. For further information, contact your Medtronic Sales Representative or call 1-763-391-9915.

Distribution

Worldwide Distribution -- United States, International West (countries included in Western Europe and the Middle East), Australia and Canada.

Quantity

508 US, 36 OUS